Securities Code: 002898
Securities Abbreviation: Sailong Delisting
Announcement Number: 2026-083
Sailong Pharmaceutical Group Co., Ltd.
Announcement on the Termination of Listing and Delisting of Company Shares
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
Special Risk Warning:
Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") shares have been decided by the Shenzhen Stock Exchange (hereinafter referred to as the "SZSE") to terminate listing. The Company's shares entered the delisting consolidation period on June 26, 2026. Trading will last for 15 trading days, with the last trading day being July 16, 2026, and delisting on July 17, 2026.
On June 17, 2026, the Company received the "Decision on Termination of Listing of Sailong Pharmaceutical Group Co., Ltd. Shares" (SZSE [2026] No. 792) from the Shenzhen Stock Exchange (hereinafter referred to as the "SZSE"). The SZSE decided to terminate the listing and trading of the Company's shares. In accordance with the relevant provisions of the "Shenzhen Stock Exchange Stock Listing Rules" and the "Implementation Measures for the Listing and Transfer of Delisted Companies in the Delisting Market," the Company shall complete relevant work in a timely manner after the termination of listing to ensure that the Company's shares can be listed and transferred in the delisting market managed by the National Equities Exchange and Quotations Company within 45 trading days after delisting.